This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, The University of Versailles Saint-Quentin-En-Yvelines. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022-2026
Title: Olivier Le Coz: Innovator in Neurogenic Detrusor Overactivity Treatment
Introduction
Olivier Le Coz is a notable inventor based in Le Mesnil Saint Denis, France. He has made significant contributions to the field of medical technology, particularly in the treatment of neurogenic detrusor overactivity (NDO). His innovative approach has led to the development of a unique pharmaceutical composition aimed at addressing this condition.
Latest Patents
Olivier Le Coz holds a patent for "Viral vectors for treating neurogenic detrusor overactivity." This invention provides a method and a pharmaceutical composition for treating NDO, utilizing a viral expression vector that carries a transcription cassette. This cassette harbors transgene(s) that inhibit or silence neurotransmission or synaptic transmission of afferent neurons, showcasing a novel approach to managing this medical issue.
Career Highlights
Throughout his career, Olivier has worked with esteemed institutions such as Université de Versailles-St Quentin En Yvelines and Assistance Publique-Hôpitaux de Paris. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Olivier has collaborated with notable professionals, including François Giuliano and Alberto Epstein. These partnerships have enriched his work and expanded the impact of his inventions in the medical community.
Conclusion
Olivier Le Coz is a distinguished inventor whose work in treating neurogenic detrusor overactivity has the potential to improve the lives of many patients. His innovative methods and collaborations highlight his commitment to advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile